Medical Marijuana Inc (OTCMKTS:MJNA) Stock Jumps 10% in a Week: But Why?

Medical Marijuana Inc (OTCMKTS:MJNA) has a special space in the industry for having the distinction of being the very first publicly traded cannabis firm in the United States.

Trading Data

On Monday, MJNA stock rose 0.09% at $0.0220 with more than 11.94 million shares, compared to its average volume of 8.33 million shares. The stock has moved within a range of $0.0200 – 0.0230 after opening the trade at $0.0210.

Subsidiary Kannaway® Announces Promotion of Peter Dale to Global Chief Sales Officer

Over the course of the past week the stock has made a strong move and has managed to deliver gains of as much as 10%. As a matter of fact, the Medical Marijuana stock was in the news yesterday after it made a key announcement with regards to its subsidiary company Kannaway. It was announced that Peter Dale, who was the General Manager of the Japan Division, had been promoted to the post of the Global Chief Sales Officer.

It was a significant announcement from the company considering the fact that the designation is expected to play an important part in Kannaway’s growth in the near future. In his new role, Dale is going to be in charge of the global business development and sales processes. He is also going to be responsible for building strategies, teams and processes. In addition to that, he is going to be involved in growing the current sales team which is in place at Kannaway. It might be a good idea to add the Medical Marijuana stock to your watch lists at this point.

Key Quote

“​​Peter has been instrumental in the growth with our entrepreneur leaders in Japan and throughout Asia and we believe that he is capable of successfully leading our sales operations globally,” said Kannaway® CEO Blake Schroeder. “His dedication to our mission and vision is inspiring and I hope that he can share his passion with even more people than ever before in his new role.”

Technical Data

MJNA stock is trading below the 20-Day and 50-Day Moving averages of $0.0242 and $0.0267 respectively. Moreover, the stock is trading below 200-Day moving average of $0.0421. The stock is down 14% in the past month.